Ms. Susan Fentress

US Legal Advisor

  • B.S. Biochemistry and Psychology in University of Wisconsin (1980)
  • J.D. Staff Editor, Marquette Law Review in Marquette University Law School (1983)
  • 24 Graduate credits in Molecular Biology in University of Wisconsin – Milwaukee (1983)

Ms. Fentress is presently admitted as an Attorney in the states of Wisconsin , Illinois and Tennessee , U.S.A. She is also a registered patent attorney. She obtained a B.S. in biochemistry from the University of Wisconsin (1980), and a J.D. from Marquette University in 1983. Her expertise includes patent litigation with the firm of Neuman, Williams, Anderson, Olson –as counsel in DuPont v. Phillips Petroleum Corp. E.I. DuPont de Nemours v. Phillips Petroleum Co. , Counsel, District of Delaware, patent infringement suit covering ethylene copolymers. Subsequently, she was Division Counsel for Baxter Health Care Diagnostic Division in charge of litigation and prosecution for this division. Representative cases include: Abbott Laboratories v. Baxter Healthcare Corp., District N.D. California (Paramax Chemical Analyzer); Baxter Health Care v. Abbott Labor, N.D. Illinois (Stratus Immunochemical Analyzer); Baxter Healthcare Corp. v. LKB Diagnostic (Patient Validity Action, Munich , Germany).

Ms. Fentress is familiar with Greater China, having visited and interacted with the technology community in Both China and Hong Kong. She has given several international speeches including: “First Step to America. A Legal Consulting Seminar for Investment and Trade in the US” in Nanjing, PRC; “Patent Related Issues for Products Imported into the United States” for the International Drug Discovery Science and Technology Conference in Shanghai, China and “Cost Efficient Patent Litigation in the US” at Hong Kong Science Park.

Besides China, Ms Fentress also has interest and experience in IP protection worldwide, including other Asian countries, such as India. She has given seminars on “Risk Management Issues with Global Development of Biomedical Products” for the Global Alliance of the Indian Biomedical Professional Annual Conference; “Taming the Intellectual Property Beast: Views from India and China” for the General Counsel Institute; “Protection of Pharmaceuticals” in China for AIPLA; and ” Comparison of Patent Protection for Chemical Inventions among Canada, US and Europe” for the American Chemical Society’s ‘Chemistry and the Law’ Symposium, Joint Regional Meeting.

Ms. Fentress was Division counsel for Baxter Health Care Diagnostics Division and prepared numerous agreements for Baxter. These agreements included; NDA, Supported Research Agreement with Universities, Patent License Agreements (to resolve patent disputes); term sheet for deals and IP portions of acquisition, divestiture and joint ventures agreements. As a legal counsel at HSHW, she has prepared manufacturing and distribution contracts, including FDA compliant quality agreements for medical devices. She has similarly, prepared numerous IP license agreements relating to patents, trademark and trade-secrets for medical devices. She has published and spoke on transactional issues. Some recent activities include: LES Annual Convention, Oct.2009 Due Diligence for Medical Device Transactions ; Published paper. Journal of Licensing Fall 2008 on “Protection of IP in China through Contracts and Good Business Practices” and Featured speaker, “Risk Management issues with Global Development of Biomedical Products, Global Alliance of Indian Biomedical Professional”, annual Conference June 7th 2008. Susan assists EIP in patent and trademark registration.

Her working language is English.